Shortening treatment of tuberculosis: lessons from fluoroquinolone trials. (2015)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(14)70885-0
PubMed Identifier: 25749057
Publication URI: http://europepmc.org/abstract/MED/25749057
Type: Journal Article/Review
Volume: 15
Parent Publication: The Lancet. Infectious diseases
Issue: 2
ISSN: 1473-3099